Search

Author/Creator Bain, Earle

1. ACTR-21. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF DEPATUXIZUMAB MAFODOTIN (ABT-414) IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED (AMP) NEWLY DIAGNOSED GLIOBLASTOMA (nGBM). (11th November 2019)

Authors:
Lassman, Andrew; Pugh, Stephanie; Wang, Tony; Aldape, Kenneth; Gan, Hui; Preusser, Matthias; Vogelbaum, Michael; Sulman, Erik; Won, Minhee; Zhang, Peixin; Moazami, Golnaz; Macsai, Marian; Gilbert, Mark; Bain, Earle; Blot, Vincent; Ansell, Peter; Samanta, Suvajit; Kundu, Madan; Seidel, Clemens; De...
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. CTNI-51. NEUROCOGNITIVE FUNCTION (NCF) OUTCOMES OF RTOG FOUNDATION 3508: A PHASE 3 TRIAL OF ABT-414 WITH CONCURRENT CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH EGFR-AMPLIFIED NEWLY DIAGNOSED GBM. (9th November 2020)

Authors:
Wefel, Jeffrey S; Won, Minhee; Lassman, Andrew; Stern, Yaakov; Wang, Tony; Aldape, Kenneth; Armstrong, Terri; Vogelbaum, Michael; Sulman, Erik; Moazami, Golnaz; Macsai, Marian; Gilbert, Mark; Bain, Earle; Blot, Vincent; Gan, Hui; Preusser, Matthias; Ansell, Peter; Samanta, Suvajit; Kundu, Madan; ...
Journal:
Neuro-oncology
Issue:
Volume 22(2020)Supplement 2
Page Start:
ii54
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand. Issue 1 (9th December 2019)

Authors:
Hoogstrate, Youri; Vallentgoed, Wies; Kros, Johan M; de Heer, Iris; de Wit, Maurice; Eoli, Marica; Sepulveda, Juan Manuel; Walenkamp, Annemiek M E; Frenel, Jean-Sebastien; Franceschi, Enrico; Clement, Paul M; Weller, Micheal; van Royen, Martin E; Ansell, Peter; Looman, Jim; Bain, Earle; Morfouace...
Journal:
Neuro-oncology advances
Issue:
Volume 2:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. HGG-15. PHASE 2 NESTED COHORT STUDY OF DEPATUXIZUMAB MAFODOTIN IN CHILDREN WITH HIGH GRADE GLIOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA WITH EGFR AMPLIFICATION. Issue 2 (22nd June 2018)

Authors:
van den Bent, Martin; Dinjens, Winand; Golfinopoulos, Vassilis; Ansell, Peter; Dungey, Fiona; de Geus, Jan Peter; Bain, Earle; Looman, Jim; Xiong, Hao; Hargrave, Darren
Journal:
Neuro-oncology
Issue:
Volume 20:Issue 2(2018)supplement 2
Page Start:
i91
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial. Issue 1 (5th July 2018)

Authors:
Lassman, Andrew B; van den Bent, Martin J; Gan, Hui K; Reardon, David A; Kumthekar, Priya; Butowski, Nicholas; Lwin, Zarnie; Mikkelsen, Tom; Nabors, Louis B; Papadopoulos, Kyriakos P; Penas-Prado, Marta; Simes, John; Wheeler, Helen; Walbert, Tobias; Scott, Andrew M; Gomez, Erica; Lee, Ho-Jin; Rob...
Journal:
Neuro-oncology
Issue:
Volume 21:Issue 1(2019)
Page Start:
106
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗